Geneva: The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director General Tedros Adhanom Ghebreyesus said.
“Nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity trial,” he told a news briefing, referring to clinical studies the U.N. agency is conducting.
“We expect interim results within the next two weeks.”
The Solidarity Trial started out in five parts looking at possible treatment approaches to COVID-19: standard care; remdesivir; the anti-malaria drug touted by U.S. President Donald Trump, hydroxychloroquine; the HIV drugs lopinavir/ritonavir; and lopanivir/ritonavir combined with interferon.
While a vaccine candidate might show its effectiveness by year’s end, the question was how soon it could be mass produced, he told the U.N. journalists’ association ACANU in Geneva.
There is no proven vaccine against the disease now, while 18 potential candidates are being tested on humans.